Sort
48,018 grants matching “immunotherapy”
Heteropolymer System to Treat Vaccinia Complications
$640,264Elusys Therapeutics, Inc. · U01 · FY2004 · AI
Targeting Immunosuppression Pathways to Enhance Brain Tumor Immunotherapy
$640,259John H Sampson · Duke University · P01 · FY2015 · CA
Exploiting the Mechanobiology of PD-1 for Cancer Immunotherapy
$640,183Cheng Zhu · Georgia Institute Of Technology · U01 · FY2021 · CA
Serial immunotherapy combination to modulate the tumor environment in patients with metastatic gastroesophageal cancer
$640,182Harry H Yoon · Mayo Clinic Rochester · R01 · FY2021 · CA
Translating Pediatric Cancer Proteogenomic Data into Biological and Clinical Insights
$640,150Bing Zhang · Baylor College Of Medicine · U24 · FY2025 · CA
Molecular Imaging Guidance for Potentiating Chemoimmunotherapy in Pancreatic Cancer using Photodynamic Priming
$640,089Girgis Obaid · University Of Texas Dallas · R01 · FY2024 · EB
Enhancing the Effectiveness of Immunotherapies by T Cell Epigenetic Reprogramming
$640,056Hazem E. Ghoneim · Ohio State University · R01 · FY2024 · AI
Enhancing the Effectiveness of Immunotherapies by T Cell Epigenetic Reprogramming
$640,056Hazem E. Ghoneim · Ohio State University · R01 · FY2025 · AI
Enhancing the Effectiveness of Immunotherapies by T Cell Epigenetic Reprogramming
$640,056Hazem E. Ghoneim · Ohio State University · R01 · FY2023 · AI
Computational Modeling Aggressive Brain Cancer
$639,896Orit Lavi · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
CD38, T cells and post viral lung sequelae during aging
$639,740Jie Sun · University Of Virginia · R01 · FY2025 · AG
KIR and HLA effects in CNS paraneoplastic syndromes and related neuroimmune conditions
$639,718Emmanuel J Mignot · Stanford University · U01 · FY2023 · NS
Immunotherapy via engineered therapeutic programs in tumors using RNA
$639,680Ron Weiss · Massachusetts Institute Of Technology · U01 · FY2025 · CA
Immunotherapeutic Modulation of Peanut Allergy
$639,644Scott H Sicherer · Icahn School Of Medicine At Mount Sinai · U19 · FY2007 · AI
Personalized vaccine immunotherapy in combination with anti-PD 1 antibody for recurrent or metastatic squamous cell carcinoma of the head and neck
$639,614Dong Moon Shin · Emory University · R01 · FY2024 · CA
Strategies for Cancer Immunotherapy Clinical Trials
$639,565Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
The Impact of FUS-Mediated Brain Cancer Therapy on BBB Transport, Cytokines, and Immunocyte Trafficking
$639,521Kim Butts Pauly · Stanford University · R01 · FY2018 · CA
Studies of Human T Regulatory Cells
$639,496Ethan Shevach · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Strategies for Therapeutic Cancer Vaccine Clinical Trials
$639,402Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Project 1: Clinical and immune impact of radiation and dual checkpoint blockade in patients
$639,331Robert H Vonderheide · University Of Pennsylvania · P01 · FY2022 · CA
Serial immunotherapy combination to modulate the tumor environment in patients with metastatic gastroesophageal cancer
$639,268Harry H Yoon · Mayo Clinic Rochester · R01 · FY2022 · CA
Mechanisms of BET bromodomain metabolic reprogramming in triple negative breast cancer
$639,256Gerald V Denis · Boston University Medical Campus · R01 · FY2020 · CA
Targeting Immunosuppression Pathways to Enhance Brain Tumor Immunotherapy
$639,245John H Sampson · Duke University · P01 · FY2016 · CA
Defining the β-catenin/CBP-catenin/CBP axis in head and neck cancer
$639,175Maria A Kukuruzinska · Boston University Medical Campus · R01 · FY2022 · DE
(8) Genomic determinants of the T-cell regulome in immune checkpoint blockade
$639,149Tomas Kirchhoff · New York University School Of Medicine · R01 · FY2020 · CA